Anthracycline-conjugates
US5776458A · kind A · utility
16Cited by
7References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 1995 |
| Grant date | Jul 7, 1998 |
| Priority date | — |
| Expiry date | Mar 27, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides anthracycline conjugates with carriers such as monoclonal polyclonal antibodies, proteins or peptides, or other synthetic carriers. These anthracycline conjugates provide pharmaceutical compositions which are useful for treating certain mammalian tumors. The compounds of the present invention have higher potency than anthracyclines, and improved therapeutic efficacy and reduced toxic effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.